comparemela.com
Home
Live Updates
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases : comparemela.com
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases
/PRNewswire/ -- The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, announced today that AbbVie...
Related Keywords
Jonathon Sedgwick
,
Travis Young
,
Scripps Research
,
Calibr Skaggs Institute For Innovative Medicines
,
Calibr Skaggs Institute
,
Innovative Medicines
,
comparemela.com © 2020. All Rights Reserved.